Pharma Stocks Ki Dhamakedar Chalaang! Global Risks Aur Girte Rupee Ne Diya Support

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorKavya Nair|Published at:
Pharma Stocks Ki Dhamakedar Chalaang! Global Risks Aur Girte Rupee Ne Diya Support
Overview

Indian Pharma Stocks aaj market ko peeche chhod rahe hain. Global tensions aur kamzor rupee ki wajah se ye sector safe haven bana hua hai. Companies zabardast earnings bhi report kar rahi hain.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Duniya mein Tension, India mein Pharma Ka Jashn!

Bhai log, jab bhi duniya mein kuch gadbad hoti hai na, toh pharma stocks bade solid rehte hain. Aur is baar bhi wahi ho raha hai. Global tensions aur Indian Rupee ka girna, is pharma sector ke liye jackpot sabit ho raha hai.

Nifty Pharma Ki Tohareef!

Jabki Nifty50 9.5% neeche chala gaya hai, Nifty Pharma index 10.07% upar hai. Iska reason simple hai: log medicine lena band nahi karte, chahe economy kaisi bhi ho. Geojit Investments ke VK Vijayakumar bhi yahi keh rahe hain ki medicine ki demand health needs par depend karti hai, price par nahi.

Rupee Ka Fayda

Aur haan, Indian Rupee jab ₹96.96 ke record low par pahunch gaya hai, toh pharma exporters ki toh lottery lag gayi hai. USA aur Europe jaise markets se jo paisa aata hai, woh ab rupee mein zyada ho gaya hai. Isse companies ki pockets garam ho gayi hain.

Asli Kamai, Asli Growth!

Baki sectors tech aur AI ke valuations mein uljhe hain, par pharma companies real earnings dikha rahi hain. Q4FY26 mein kai companies ne double-digit growth report kiya hai. Is wajah se Aurobindo Pharma 26.8%, Gland Pharma 25.2%, Laurus Labs 19.8%, Sun Pharma 10.5% aur Cipla 4.6% tak badh gaye hain.

Kahan Invest Karein?

Experts keh rahe hain ki API (Active Pharmaceutical Ingredient) aur CDMO (Contract Development and Manufacturing Organization) companies par focus karo. Long term ke liye Sun Pharma, Lupin, Torrent Pharma aur Mankind Pharma jaise bade players achhe options hain.

Kuch Numbers Dekho (May 2026 Tak)

  • Sun Pharma: P/E ~41.52, Market Cap ~₹4.54 trillion.
  • Aurobindo Pharma: P/E ~25.3, Market Cap ~₹88,160 crore.
  • Gland Pharma: P/E ~35.63, Market Cap ~₹37,050 crore.
  • Mankind Pharma: P/E ~55.04, Market Cap ~₹1,06,669 crore.
  • Laurus Labs: P/E ~82.55, Market Cap ~₹73,491 crore.
  • Cipla: Market Cap ~₹1,13,052 crore.

Par Dhyan Rakhna!

Sab kuch achha nahi hai. Regulatory approvals mein dikkat aa sakti hai, aur kuch stocks jaise Laurus Labs (P/E 81.95) aur Mankind Pharma (P/E 57.18) ka valuation bahut high hai. Competition bhi badh raha hai. Toh thoda soch samajh kar hi paisa lagana, bhai!

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.